StockNews.com downgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Get Rating) from a hold rating to a sell rating in a report released on Friday. Separately, EF Hutton Acquisition Co. I restated a buy rating and issued a $10.00 price objective on shares of CEL-SCI in a report on Thursday, March 9th. CEL-SCI Trading Up 2.7 % […]
StockNews.com started coverage on shares of CEL-SCI (NYSE:CVM – Get Rating) in a research note released on Thursday. The brokerage issued a hold rating on the stock. CEL-SCI Price Performance Shares of NYSE:CVM traded up $0.08 during midday trading on Thursday, reaching $2.64. The company had a trading volume of 5,553 shares, compared to its […]
StockNews.com started coverage on shares of CEL-SCI (NYSEAMERICAN:CVM – Get Rating) in a research note published on Thursday. The firm issued a hold rating on the stock. Separately, EF Hutton Acquisition Co. I reissued a buy rating and set a $10.00 target price on shares of CEL-SCI in a research report on Thursday, March 9th. […]
CEL-SCI Co. (NYSEAMERICAN:CVM – Get Rating) saw a significant increase in short interest in April. As of April 30th, there was short interest totalling 6,040,000 shares, an increase of 8.1% from the April 15th total of 5,590,000 shares. Based on an average daily volume of 187,400 shares, the days-to-cover ratio is currently 32.2 days. Analyst […]
Surrozen (NASDAQ:SRZN – Get Rating) and CEL-SCI (NYSE:CVM – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Valuation and Earnings This table compares Surrozen and CEL-SCI’s gross revenue, […]